New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Lineage Cell Therapeutics, Inc.
LCTX
Shape
US Flag

AMEX

Unprofitable

EPS improving

Unprofitable

EPS improving

153M

Biotechnology

Next Earning date - 06 Mar 2025

153M

Biotechnology

Next Earning date - 06 Mar 2025

0.69USD

Shape0.01 ( 1.45%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

2
favorite-chart

Volume Buzz

-71%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

57%

Quote Panel

Shape
Updated February 17, 2025
1W 6.24 % 1M 18.10 % 3M -20.97 % 1Y -36.25 %

Key Metrics

Shape
  • Market Cap

    153.17M


  • Shares Outstanding

    220.42M


  • Share in Float

    219.43M


  • Dividende

    0


  • Earning Date

    06 Mar 2025


  • Price Target

    0.6949


  • Average Volume

    2.73M


  • Beta

    1.212


  • Range

    0.48-1.61


  • Industry

    Biotechnology


  • Website

    https://www.lineagecell.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

LCTX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$12M

Shape207%

2025-Revenue

$0.10

Shape-531%

2025-EPS

$12M

Shape-213%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Craig-Hallum

initialise

Previous: Not converted

2024-08-20

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.03
vs -0.05

Q1.23

arrow
arrow

N/A

-0.03
vs -0.04

Q2.23

arrow
arrow

N/A

-0.03
vs -0.04

Q3.23

arrow
arrow

N/A

-0.04
vs -0.04

Q4.23

arrow
arrow

N/A

-0.03
vs -0.03

Q1.24

arrow
arrow

N/A

-0.04
vs -0.03

Q2.24

arrow
arrow

N/A

-0.03
vs -0.03

Q3.24

arrow
arrow

N/A

-0.02
vs -0.04

Q4.24

arrow
arrow

N/A

-0.02
vs -0.03

Q1.25

arrow
arrow

N/A

-0.04
vs -0.04

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+99%

1.9M  vs 960K

Q1.23

arrow
arrow

-54%

2.4M  vs 5.2M

Q2.23

arrow
arrow

-29%

3.2M  vs 4.6M

Q3.23

arrow
arrow

-58%

1.2M  vs 3M

Q4.23

arrow
arrow

+9%

2.1M  vs 1.9M

Q1.24

arrow
arrow

-39%

1.4M  vs 2.4M

Q2.24

arrow
arrow

-56%

1.4M  vs 3.2M

Q3.24

arrow
arrow

+203%

3.8M  vs 1.2M

Q4.24

arrow
arrow

-22%

1.6M  vs 2.1M

Q1.25

arrow
arrow

-6%

1.4M  vs 1.4M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-9%

-0.09
vs -0.08

Q1.23

arrow
arrow

-6%

-0.06
vs -0.09

Q2.23

arrow
arrow

-7%

-0.07
vs -0.06

Q3.23

arrow
arrow

-10%

-0.10
vs -0.07

Q4.23

arrow
arrow

-8%

-0.08
vs -0.10

Q1.24

arrow
arrow

-9%

-0.09
vs -0.08

Q2.24

arrow
arrow

-8%

-0.08
vs -0.09

Q3.24

arrow
arrow

-5%

-0.05
vs -0.08

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

117

117
vs 103

14%

Q2.23

arrow
arrow

107

107
vs 117

-9%

Q3.23

arrow
arrow

104

104
vs 107

-3%

Q4.23

arrow
arrow

115

115
vs 104

11%

Q1.24

arrow
arrow

115

115
vs 115

NA

Q2.24

arrow
arrow

114

114
vs 115

-1%

Q3.24

arrow
arrow

114

114
vs 114

NA

Q4.24

arrow
arrow

81

81
vs 114

-29%

Earnings Growth

Latest News